Cmpx stock forecast.

Compass Therapeutics, Inc. (CMPX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.6500 -0.0700 (-4.07%) At close: 04:00PM EST 1.6500 0.00 (0.00%) After hours: 04:20PM EST...Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Apexigen APGN Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.Compx International Inc: A High-Performing Stock with a GF Score of 93. GF Score analysis. Find the latest CompX International Inc. (CIX) stock quote, history, news and other vital information to ...13 may 2022 ... ... stock price fluctuations. StockWatch appears weekly in GEN Edge ... Compass Therapeutics (CMPX). Shares of Compass soared 25% on Thursday ...CMPX Stock Forecast 2023. Compass Therapeutics boasts a robust drug pipeline, which explains why analysts are bullish on the stock. The Phase 2 and Phase 3 studies for cancer drug CTX-009 extend into H2 2023, at which time the company plans to initiate a Phase 1 study for its CTX-8371 drug also for cancer after filing an Investigational New Drug Application (IND) earlier in 2023.

Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.

The Compass Therapeutics stock forecast for tomorrow is $ 1.516608, which would represent a -1.52% loss compared to the current price. In the next week, the price of CMPX is expected to decrease by -2.77% and hit $ 1.497361. As far as the long-term Compass Therapeutics stock forecast is ...

Price Target Upside/Downside. According to analysts' consensus price target of $9.33, Compass Therapeutics has a forecasted upside of 465.2% from its current price of $1.65. Amount of Analyst Coverage. Compass Therapeutics has received no research coverage in the past 90 days.What this means: InvestorsObserver gives Compass Therapeutics Inc. (CMPX) an overall rank of 34, which is below average. Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...The Compass Therapeutics stock forecast for tomorrow is $ 1.516608, which would represent a -1.52% loss compared to the current price. In the next week, the price of CMPX is expected to decrease by -2.77% and hit $ 1.497361. As far as the long-term Compass Therapeutics stock forecast is ...

This brings the total capital commitment to the Fund to $1.8 billion. Find the latest Power Corporation of Canada (POW.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.

CompX International Inc. (NYSE:CIX) posted its quarterly earnings data on Wednesday, November, 1st. The company reported $0.47 earnings per share for the quarter. The business earned $40.30 million during the quarter. CompX International had a net margin of 13.09% and a trailing twelve-month return on equity of 12.79%.

Buy a little, but exit at $42.25. (CPX-T) They successfully transitioned from coal to gas and other green energy. An excellent long-term performer, but 27% over 3 years. Was up last year in a down year. (CPX-T) Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Business sensitive to Alberta market.Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buyCMPX · CLLS · RPHM · ZURA. Company name. Compass Therapeutics, Inc. Cellectis S.A.. Reneo Pharmaceuticals, Inc. Zura Bio Limited. Industry. Biotechnology ...Nov 8, 2023 · Predictions of CMPX stock price for tomorrow. Compass Therapeutics Inc. (CMPX) stock is trading at $3.76 as of 3:42 PM on Friday, Jan 20, a gain of $0.01, or 0.27% from the previous closing price of $3.75. Volume today is above average. So far 918,164 shares have traded compared to average volume of 271,877 shares. The stock has traded between $3.20 and $3.88 so far today.

Milestone Pharmaceuticals (MIST) Stock Forecast, Price ...Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Nov 29, 2023 · CompX International Inc. (NYSE:CIX) posted its quarterly earnings data on Wednesday, November, 1st. The company reported $0.47 earnings per share for the quarter. The business earned $40.30 million during the quarter. CompX International had a net margin of 13.09% and a trailing twelve-month return on equity of 12.79%. According to . 1 Wall Street analyst that have issued a 1 year PSTV price target, the average PSTV price target is $8.00, with the highest PSTV stock price forecast at $8.00 and the lowest PSTV stock price forecast at $8.00.

According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00.Dec 1, 2023 · 4 brokers have issued twelve-month target prices for Catalyst Pharmaceuticals' stock. Their CPRX share price targets range from $24.00 to $27.00. On average, they predict the company's stock price to reach $24.75 in the next twelve months. This suggests a possible upside of 67.0% from the stock's current price.

Find the latest Compass Therapeutics, Inc. (CMPX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.What this means: InvestorsObserver gives Compass Therapeutics Inc. (CMPX) an overall rank of 34, which is below average. Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.Their COEP share price targets range from $3.00 to $6.00. On average, they expect the company's stock price to reach $4.33 in the next twelve months. This suggests a possible upside of 270.4% from the stock's current price. View analysts price targets for COEP or view top-rated stocks among Wall Street analysts.Stock Price Forecast. The 5 analysts offering 12-month price forecasts for CompoSecure Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 7.00. The median ... Gas prices are at a record high, and experts are forecasting that prices could go higher this summer — perhaps $5 or even over $6 a gallon. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I a...SOS Limited - ADR Stock Forecast, SOS stock price prediction. Price target in 14 days: 4.203 USD. The best long-term & short-term SOS Limited - ADR share price ...Future criteria checks 0/6. Compass Therapeutics is forecast to grow earnings and revenue by 21.6% and 76.7% per annum respectively while EPS is expected to grow by 25.3% per annum.Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buy

The consensus price target of analysts on Wall Street is $2.50, which implies an increase of 83.2% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.50 and $2.50 respectively. As a result, VGZ is trading at a discount of -495.24% off the target high and -495.24% off the low.

The above table shows the analyst CMPX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$1.77

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.GTHX Stock 12 Months Forecast. $9.00. (429.41% Upside) Based on 3 Wall Street analysts offering 12 month price targets for G1 Therapeutics in the last 3 months. The average price target is $9.00 with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 429.41% change from the last price of $1.70.Based on short-term price targets offered by seven analysts, the average price target for Compass Therapeutics, Inc. comes to $9.33. The forecasts range from a low of $8.00 to a high of $11.00 ... PAYO Stock 12 Months Forecast. $8.80. (56.58% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Payoneer in the last 3 months. The average price target is $8.80 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 56.58% change from the last price of $5.62.The average Cabaletta Bio stock price prediction forecasts a potential upside of 75.22% from the current CABA share price of $18.67. What is CABA's forecast return on equity (ROE) for 2023-2026? (NASDAQ: CABA) forecast ROE is N/A, which is considered weak.Stock price analysis for Compass Therapeutics, Inc. (CMPX), stock quote, stock research, rsi, macd, support, resistance and most important highlights.All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.The above table shows the analyst CMPX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$1.77 Find real-time CIX - CompX International Inc stock quotes, company profile, news and forecasts from CNN Business.Nov 24, 2023 · The ALX Oncology Holdings Inc. stock price fell by -4.02% on the last day (Friday, 24th Nov 2023) from $9.21 to $8.84. During the last trading day the stock fluctuated 10.18% from a day low at $8.79 to a day high of $9.69. The price has risen in 6 of the last 10 days and is up by 12.76% over the past 2 weeks. CMPX : 3.36 (+8.74%) Compass Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update Globe Newswire - Mon Mar 21, 2022. Ended 2021 with $144.5 million in cash and cash equivalentsCTX-009 (DLL4 X VEGF-A bispecific antibody) Global Phase 2 study in patients with advanced...

$10.50 (510.47% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $10.50 with a …PAYO Stock 12 Months Forecast. $8.80. (56.58% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Payoneer in the last 3 months. The average price target is $8.80 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 56.58% change from the last price of $5.62. This brings the total capital commitment to the Fund to $1.8 billion. Find the latest Power Corporation of Canada (POW.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.Instagram:https://instagram. tax rate on day tradinghow to start trading forexmajor forex brokersreviews of ambetter insurance Learn more about whether Compass Therapeutics Inc. is a good stock to buy or sell based on recent news as well as its key financial metrics. Read on to find out how grades on certain investment factors and determine whether it meets your investment needs.. Latest Compass Therapeutics Inc. Stock NewsTop Analysts Based on 1 analyst offering 12 month price targets for Compass Therapeutics Inc. Min Forecast $10.00 +528.93% Avg Forecast $10.00 +528.93% Max Forecast … best scalping strategyforex platform for beginners Price Target Upside/Downside. According to analysts' consensus price target of $9.33, Compass Therapeutics has a forecasted upside of 465.2% from its current price of $1.65. Amount of Analyst Coverage. Compass Therapeutics has received no research coverage in the past 90 days. speedtrader Compass Therapeutics, Inc. - Hold. Zacks' proprietary data indicates that Compass Therapeutics, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the CMPX shares ...27.27%. ABR. 1.38. Earnings ESP. More Info. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea ...